Mercury Laboratories Ltd
Mercury Laboratories (BSE)


Proj. ROE (%)
Proj. P/E (x)
Proj EV / EBITDA (x)
Proj. P/BV (x)
Proj. Revenue ( Cr.)

Stock View

Share on
The average score for Mercury Laboratories Ltd stands at 7 against 5, three months back.

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations. The Company’s products include Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant, Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti-malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin, Protein supplement, Respiratory System, Anti- allergic, Steroids, Urinary system, Uterine stimulant and Miscellaneous. Its products also include Gynec, Paediatric, Surgeon, Physician, Antihypertensive (PIH), PCOS & Uterine Disorders, Galactagogue, Haemostat, Iron and Vitamins, Preterm Labor Management, Antiemetic, Dexamethasone Tablet, Glucosamine Sulphate, Prednisolone Acetate Ophthalmic Suspension USP, Ketorolac Tromethamine 0.4% Eye Drops and Ketorolac Tromethamine 0.4% Eye Drops.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
100 DMA ()
200 DMA ()
52 Weeks Range
Street View :-
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity